Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

BioCorRx (BICX) Leases (2019 - 2025)

BioCorRx (BICX) has disclosed Leases for 9 consecutive years, with $159128.0 as the latest value for Q4 2025.

  • Quarterly Leases fell 20.11% to $159128.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $159128.0 through Dec 2025, down 20.11% year-over-year, with the annual reading at $159128.0 for FY2025, 20.11% down from the prior year.
  • Leases hit $159128.0 in Q4 2025 for BioCorRx, down from $169443.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $464245.0 in Q1 2021 to a low of $70658.0 in Q1 2024.
  • Historically, Leases has averaged $253726.1 across 5 years, with a median of $213596.5 in 2023.
  • Biggest five-year swings in Leases: crashed 70.57% in 2024 and later surged 168.15% in 2025.
  • Year by year, Leases stood at $384921.0 in 2021, then fell by 29.75% to $270406.0 in 2022, then tumbled by 64.03% to $97278.0 in 2023, then skyrocketed by 104.76% to $199184.0 in 2024, then decreased by 20.11% to $159128.0 in 2025.
  • Business Quant data shows Leases for BICX at $159128.0 in Q4 2025, $169443.0 in Q3 2025, and $179555.0 in Q2 2025.